Bronnen:
- Matthay MA, Calfee CS, Zhuo H, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2018 Nov 16. pii: S2213-2600(18)30418-1. [Epub ahead of print]